LePure Biotech Closes Series C Financing Co-Led by Novo Holdings, General Atlantic, and Goldman Sachs Asset Management
- Written by PR Newswire
- LePure Biotech is a leading provider of high-quality and innovative single-use bioprocessing solutions in China
- Proceeds will be used to continue to accelerate product innovation and advance LePure Biotech's go-to-market strategy
SHANGHAI, Jan. 17, 2023 /PRNewswire/ -- Shanghai LePure Biotech Co., Ltd. ("LePure" or "LePure Biotech") announced the...














